KNVKF Kinnevik AB Class B

Kinnevik appoints Erika Söderberg Johnson as Chief Financial Officer

Kinnevik appoints Erika Söderberg Johnson as Chief Financial Officer

Kinnevik AB (publ) (“Kinnevik”), today announced that it has appointed Erika Söderberg Johnson as Chief Financial Officer. Erika Söderberg Johnson joins Kinnevik from Biotage where she has been CFO since 2012 and she will take up her position at the latest on 6 April 2020. 

Georgi Ganev, CEO of Kinnevik, commented, “I am very pleased to welcome Erika to Kinnevik. She brings a wealth of experience including working as a CFO in fast growing listed medtech businesses, board work in Saab and Qliro Group and deep understanding of corporate finance from her early career in investment banking. I am confident that she will be a great addition to Kinnevik’s management team and add valuable insights to our portfolio companies.“

Prior to joining Biotage, Erika Söderberg Johnson was Chief Financial Officer at Karo Bio (2007-2011), Affibody (2005-2007) and Global Genomics (2002-2005) and she has been a board member of Sectra AB and MedCap AB. Erika Söderberg Johnson also worked ten years in Investment Banking and Corporate Finance at SEB Enskilda. She is a board member of publicly listed companies Saab AB (since 2017) and Qliro Group AB (since 2017). Erika Söderberg Johnson was born in 1970 and has a M.Sc. BA from Stockholm School of Economics.

For further information, visit or contact:

Torun Litzén, Director Investor Relations

Phone +46 (0)70 762 00 50

Email

Kinnevik is an industry focused investment company with an entrepreneurial spirit. Our purpose is to build the digital consumer businesses that provide more and better choice. We do this by working in partnership with talented founders and management teams to create, invest in and lead fast growing businesses in developed and emerging markets. We believe in delivering both shareholder and social value by building well governed companies that contribute positively to society. Kinnevik was founded in 1936 by the Stenbeck, Klingspor and von Horn families. Kinnevik’s shares are listed on Nasdaq Stockholm’s list for large cap companies under the ticker codes KINV A and KINV B.

Attachment

EN
01/10/2019

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Kinnevik AB Class B

Kinnevik AB: 1 director

A director at Kinnevik AB bought 7,500 shares at 68.040SEK and the significance rating of the trade was 62/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sh...

Joachim Gunell
  • Joachim Gunell

The weekly navigator

Key takeaways from last week: 1) VEF’s largest holding Creditas announced a milestone partnership with Nubank; 2) Kinnevik invested USD100m in US mental health benefits platform Spring Health; 3) Aker is to sell its 62% stake in Ocean Yield; and 4) Svolder reported its year-end results.

Joachim Gunell
  • Joachim Gunell

The weekly navigator

Key takeaways from last week: 1) Latour invests in battery charger supplier CTEK in conjunction with the latter’s planned IPO; 2) Kinnevik will receive at least SEK2bn in extraordinary distributions post Tele2’s exit from the Netherlands; 3) Finnish SPAC Virala traded up 35%+ last week, which could improve the sentiment for Nordic SPACs; and 4) Investor-owned Sarnova acquired a strategic add-on for ~USD290m.

Joachim Gunell
  • Joachim Gunell

The weekly navigator

Key takeaways from last week: 1) Investor continues its portfolio pruning, and supported Agnafit Bidco’s SEK69bn equity value offer for Sobi; 2) we hosted VNV Global’s CEO at DNB’s Nordic TMT & Consumer Conference; and 3) we come away encouraged by Investor’s sell-side briefing on Patricia Industries.

Joachim Gunell
  • Joachim Gunell

The weekly navigator

Key takeaways: 1) we downgraded Lundbergs to SELL (HOLD) on valuation concerns; 2) Latour remains in fair valuation territory despite its high premium to reported NAV; 3) VEF completed a SEK885m directed share issue; and 4) Bloomberg reported that a consortium is weighing up an acquisition of Investor-owned SOBI.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch